Stella Sun
Overview
Explore the profile of Stella Sun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng L, Yu W, Aung N, Leung P, Luk J, Wong D, et al.
Cancer Rep (Hoboken)
. 2024 Dec;
7(12):e70069.
PMID: 39617741
Background: Colorectal cancer (CRC) is a commonly diagnosed malignancy with significant mortality rates worldwide. The identification of robust prognostic biomarkers for prediction of survival outcomes and recurrence can aid disease...
2.
Sun S, Kiang K, Leung G
Oncol Lett
. 2022 Jun;
24(2):264.
PMID: 35765277
Prolyl 4-hydroxylase beta polypeptide (P4HB) is a chaperone protein associated with temozolomide (TMZ) resistance through the unfolded protein response. Cancer cells with constitutive activation of endoplasmic reticulum stress and upregulation...
3.
Kiang K, Sun S, Leung G
Front Oncol
. 2021 Dec;
11:717793.
PMID: 34970477
Loss of heterozygosity (LOH) on chromosome 10 frequently occurs in gliomas. Whereas genetic loci with allelic deletion often implicate tumor suppressor genes, a putative tumor suppressor Adducin3 () mapped to...
4.
Sadibolova R, Sun S, Terhune D
Exp Brain Res
. 2021 Sep;
239(12):3565-3572.
PMID: 34581840
State-dependent network models of sub-second interval timing propose that duration is encoded in states of neuronal populations that need to reset prior to a novel timing operation to maintain optimal...
5.
Sun S, Kiang K, Ho A, Lee D, Poon M, Xu F, et al.
Oncotarget
. 2017 Oct;
8(42):71911-71923.
PMID: 29069756
Endoplasmic reticulum (ER) chaperone Prolyl 4-hydroxylase, beta polypeptide (P4HB) has previously been identified as a novel target for chemoresistance in glioblastoma multiforme (GBM). Yet its functional roles in glioma carcinogenesis...
6.
Zhang P, Sun S, Li N, Ho A, Kiang K, Zhang X, et al.
J Neurooncol
. 2017 Mar;
132(3):393-400.
PMID: 28293765
The chemotherapeutic agent temozolomide (TMZ) is widely used in the treatment of glioblastoma multiforme (GBM). Rutin, a citrus flavonoid ecglycoside found in edible plants, has neuroprotective and anticancer activities. This...
7.
Poon M, Zhuang J, Wong S, Sun S, Zhang X, Leung G
Anticancer Res
. 2015 Dec;
35(12):6487-95.
PMID: 26637861
Background: Glioma stem cells are associated for temozolomide-resistance in glioblastoma. Adducin 3 (ADD3) is a cytoskeletal protein associated with chemoresistance but its role in glioblastoma has not been investigated. Materials...
8.
Xu F, Wang Y, Sun S, Ho A, Lee D, Kiang K, et al.
Clin Transl Sci
. 2015 Jun;
8(5):490-4.
PMID: 26077376
RADA16-I is a synthetic type I self-assembling peptide nanofiber scaffold (SAPNS) which may serve as a novel biocompatible hemostatic agent. Its application in neurosurgical hemostasis, however, has not been explored....
9.
Xu Z, Chen Y, Gu D, Lee N, Sun S, Gong W, et al.
Am J Transl Res
. 2015 Apr;
7(2):401-10.
PMID: 25901207
Adjuvant chemotherapy is a standard therapy for gastric cancer patients, however, treatment response is quite heterogeneous. Molecular biomarkers will be highly valuable to guide the therapy and predict the response...
10.
Lee D, Sun S, Zhang X, Zhang P, Ho A, Kiang K, et al.
J Cancer
. 2015 Feb;
6(3):227-32.
PMID: 25663939
Glioblastoma multiforme (GBM) is the commonest primary brain tumour in adults characterized by relentless recurrence due to resistance towards the standard chemotherapeutic agent temozolomide (TMZ). Prolyl 4-hydroxylase, beta polypeptide (P4HB),...